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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYHuman induced pluripotent stem cells (iPSCs) can provide a promising source of midbrain dopaminergic (DA) neurons for cell
replacement therapy for Parkinson’s disease. However, iPSC-derived donor cells inevitably contain tumorigenic or inappropriate cells.
Here, we show that human iPSC-derived DA progenitor cells can be efficiently isolated by cell sorting using a floor plate marker, CORIN.
We induced DA neurons using scalable culture conditions on human laminin fragment, and the sorted CORIN+ cells expressed the
midbrain DA progenitor markers, FOXA2 and LMX1A. When transplanted into 6-OHDA-lesioned rats, the CORIN+ cells survived and
differentiated intomidbrain DA neurons in vivo, resulting in significant improvement of themotor behavior, without tumor formation.
In particular, the CORIN+ cells in a NURR1+ cell-dominant stage exhibited the best survival and function as DA neurons. Ourmethod is a
favorable strategy in terms of scalability, safety, and efficiency and may be advantageous for clinical application.INTRODUCTION
The transplantation of dopaminergic (DA) neurons repre-
sents one of the potential strategies for the treatment of
Parkinson’s disease (PD), and human pluripotent stem cells
(PSCs) are expected to be a promising source of such cells.
Residual undifferentiated stem cells or proliferating neural
progenitor cells (NPCs) with rostral identity, however, may
cause tumor formation (Roy et al., 2006; Brederlau et al.,
2006; Elkabetz et al., 2008; Doi et al., 2012). In addition,
previous clinical trials using fetal mesencephalic cells
suggested that contaminated serotonergic neurons may
cause graft-induced dyskinesia (Carlsson et al., 2007; Politis
et al., 2010). To avoid these adverse outcomes, it is critical
to eliminate the unwanted cells from the donor cell popu-
lation. As another issue, the timing of transplantation of
the donor DA neurons has to be optimized in the differen-
tiation stage in order to obtain the best survival of the
midbrain DA neurons in the brain.
To address these issues, the purification of NPCs (Fukuda
et al., 2006; Pruszak et al., 2009; Sundberg et al., 2013) and
premature or postmitotic DA neurons (Jo¨nsson et al., 2009;
Ganat et al., 2012) has been attempted. In the studies with
murine cells, premature DA neurons were found to most
effectively reduce the risk of tumor formation, as well as
to improve the motor deficits in hemiparkinsonian
rodents. Prior to the clinical application of human PSCs,Stem Cit is critical to be able to purify or enrich the DA progenitor
cells, which can be achieved by cell sorting using a cell
surface antigen. A cell surface marker specific for DA pro-
genitor cells, however, has not been identified so far.
CORIN is a serine protease, initially found in the heart,
which converts proatrial natriuretic peptide (ANP) into
ANP (Yan et al., 2000). In the developing brain, it is specif-
ically expressed in the floor plate where DA progenitor cells
are located, and mouse embryonic stem cell (ESC)-derived
DA progenitor cells could be enriched by cell sorting using
an anti-CORIN antibody (Ono et al., 2007). More recently,
mouse ESC-derived CORIN+OTX2+ cells were found
to coexpress midbrain DA progenitor markers, such as
FOXA2 and LMX1B (Chung et al., 2011). These cells
survived without tumor formation in the 6-OHDA-
lesioned rats and improved their motor dysfunction. These
results were obtained using murine ESCs, and for the clin-
ical application, it is critical to determine whether the same
strategy can be applied to human PSCs.
In the present study, we show that purification of the
CORIN+ cells generated from human induced pluripotent
stem cells (iPSCs) could enrich midbrain DA progenitor
cells. Transplantation of both the CORIN+ and the un-
sorted cells improved the behavior of 6-OHDA-lesioned
rats. However, the CORIN+ cell-derived grafts contained
more TH+ cells (a DA neuron marker) than those derived
from unsorted cells. Furthermore, the CORIN+ cell-derivedell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Authors 337
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ber of KI67+ cells (a marker of proliferating cells) compared
to those from unsorted cells. In addition, we have
optimized the timing of cell sorting and transplantation.
We also developed a scalable neural induction method
by using a xeno-free, chemically defined matrix. Taken
together, our findings provide an efficient protocol for
the clinical application of human iPSCs to treat PD.RESULTS
Midbrain DA Neurons Are Efficiently Generated by
Attachment Culture on Human Laminin Fragments
We generated midbrain DA neurons from human iPSCs
(836B3) based on a dual SMAD inhibition and floor plate
induction protocol (Chambers et al., 2009; Fasano et al.,
2010; Figure 1A), with modification for the initial attach-
ment culture.Weused recombinantE8 fragmentsofhuman
laminin 511 (LM511-E8; Miyazaki et al., 2012) instead of
the mouse sarcoma cell-derived matrix, Matrigel (MG).
This xeno-free, chemically defined matrix supported the
neural differentiation and cell survival more efficiently
than MG or another xeno-free matrix, CELLstart (CS) (Fig-
ures 1B and 1C; Figures S1A and S1B available online). In
our protocol, a GSK3b inhibitor (CHIR99021) that strongly
activates wnt signaling (Ying et al., 2008) promoted
midbrain specification, as reported previously by Kriks
et al. (2011), Kirkeby et al. (2012), and Xi et al. (2012)
(Figure S1C).
Acomparative temporalgeneexpressionanalysis revealed
that the expression of pluripotent cell markers (OCT3/4,
NANOG) gradually decreased, whereas that of a neural cell
marker (SOX1) increased until day 12 (Figure 1D). The
expression of amesodermal cellmarker (BRACHYURY) tran-
siently increased but eventually became equivalent to that
of undifferentiated iPSCs. The expression level of an endo-
dermal cellmarker (SOX17) remained low. In the expression
level analysis performed for a longer timeperiod, theexpres-
sion levels of OCT3/4 and NANOG remained low after day
12. In contrast, a midbrain marker (LMX1A) and a basal
and floor plate marker (FOXA2) reached a plateau on day
12 (Figure 1E). The expression levels of other DA neuron
markers gradually increased during the course of differenti-
ation. A flow cytometric analysis revealed that TRA-1-60+
cells (a PSC marker) had almost disappeared on day 12,
whereas PSA-NCAM+ cells (a neural cell marker) emerged
on day 7 and became the major population around day 12
(Figure 1F). TheCORIN+ cells (a floor platemarker) emerged
after day 10 and peaked around day 21–28.
Similar results with regard to the expression of these
markers were obtained with another iPSC line, 404C2 (Fig-
ures S1D–S1F). To confirm the potential of the differenti-338 Stem Cell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Authated cells to become midbrain DA neurons, the floating
spheres were replated on poly-ornithine/laminin/fibro-
nectin (O/F/L)-coated 8-well chamber slides on day 28,
then incubated for 14 days. An immunofluorescence study
performed on day 42 showed that about 40% of the total
cells expressed TH (a DA neuron marker), and most of
them coexpressed the midbrain markers, FOXA2 and
NURR1 (Figure 1G). The TH+ cells also expressed markers
for mature midbrain DA neurons, such as AADC, PITX3,
and GIRK2, and the action potentials of the neurons were
recorded by an electrophysiological analysis (Figure 1H).
Sorting of CORIN+ Cells Enriches the DA Progenitor
Cells
Based on the above results, we purified the CORIN+ cells
using fluorescence-activated cell sorting (FACS) on days
12 (Figures 2A and 2B) and 21 (Figure S2A). A quantitative
PCR analysis of the day 12 CORIN+ cells revealed that the
expression levels of midbrain markers (LMX1A and EN1)
and a basal and floor plate marker (FOXA2) were higher
in the CORIN+ cells, whereas those of a hindbrain marker
(GBX2) and a forebrainmarker (SIX3) were lower compared
to those in the unsorted and CORIN cells (Figure 2C).
Again, similar results were obtained using another iPSC
line, 404C2 (Figure S1G). A global transcriptome analysis
of the sorted and unsorted cells on day 12 disclosed that
the expression levels of rostral (PAX6), caudal (HOXA2),
early neural (NEUROG2), postmitotic neuron (NEFM), and
nonneural cell (DLK1, CYP1B1) markers were higher in
the unsorted cells (Figures S2E and S2F; Table S1). Midbrain
DA progenitor cells can be defined as those having dual
expression of LMX1A and FOXA2 (Kriks et al., 2011; Kir-
keby et al., 2012). A double-labeled immunofluorescence
study revealed that the percentage of LMX1A+/FOXA2+
cells was higher in the CORIN+ cell population compared
to the unsorted cells (75.5% ± 8.2% versus 47.3% ± 6.6%;
Figures 2D–2E). OTX2 is a transcription factor expressed
at the rostral to midbrain/hindbrain boundary. An immu-
nofluorescence study revealed that the percentage of
OTX2+/LMX1A cells (namely, rostral cells) was decreased
in the sorted CORIN+ cells (Figures 2D and 2F).
On day 21, the percentage of CORIN+ cells was higher
compared to that on day 12 (45.4% ± 14.6% versus
18.9% ± 15.4%). In this case, the expression levels of
LMX1A andFOXA2didnot change regardless of sorting (Fig-
ures S2AandS2B). Regarding thepercentage of theLMX1A+/
FOXA2+ cells, there were no significant differences between
the unsorted and the CORIN+ cells (Figures S3C and S3D).
CORIN+ Cells Exhibit Reduced Proliferation and
Differentiate into Midbrain DA Neurons
In order to investigate the characteristics of the day 12
CORIN+ cells, we continued to perform sphere culture ofors
Figure 1. Differentiation of Human iPSCs by Attachment Culture on LM511-E8
(A) An overview of the culture protocol.
(B) Phase-contrast images of the undifferentiated iPSCs on LM511-E8 on differentiation culture day 0 and day 12. Scale bars, 200 mm.
(C) The results of the flow cytometric analysis of differentiating cells on MG, CS, Laminin 111-E8 fragment (LM111), and Laminin 511-E8
fragment (LM511) on day 12. The values are the mean ± SD. *p = 0.0459 by a one-way ANOVA with Tukey’s multiple comparison test (n = 3
independent experiments).
(D and E) The results of the gene expression analysis by quantitative RT-PCR. The expression level of the undifferentiated cells (day 0) was
set to 1. The values are the mean ± SD (n = 3 independent experiments).
(F) The results of the temporal expression analysis by flow cytometry. The values are the mean ± SD (n = 4 independent experiments).
(G) Immunofluorescence images of the differentiated cells on poly-L-O/F/L-coated dishes on day 42. Scale bars, 50 mm.
(H) Current clamp recordings of induced action potentials by brief current pulses from an iPSC-derived neuron on day 42.
See also Figure S1 and Tables S5 and S6.
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Figure 2. Purification and Characterization of iPSC-Derived CORIN+ Cells on Day 12
(A) Dot plots of the FACS analysis of the unsorted and the reanalyzed sorted cells. The x-y grid indicates the intensity of 7-AAD and Alexa
488 staining, respectively.
(B) Immunostaining for CORIN (green) and DAPI (blue). Scale bars, 50 mm.
(C) The results of the gene expression analysis by quantitative RT-PCR. The expression level of the unsorted cells was set to 1. The values are
the mean ± SD. **p = 0.0080 by a one-way ANOVA with Dunnett’s multiple comparison test (n = 3 independent experiments).
(D) Immunostaining for FOXA2/LMX1A and OTX2/LMX1A. Scale bars, 100 mm.
(E and F) The percentages of LMX1A+/FOXA2+ cells (E) and OTX2+/LMX1A cells (F) per the total number of cells. The values are the mean ±
SD. **p = 0.0046 (E), **p = 0.0013 (F), and ****p < 0.0001 by a one-way ANOVA with Dunnett’s multiple comparison test (n = 5 different
experiments).
See also Figures S1 and S2 and Tables S5 and S6.
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Isolation of hiPSC-Derived DA Progenitors to Graftthe sorted cells in the presence of brain-derived neuro-
trophic factor (BDNF) and glial cell-derived neurotrophic
factor (GDNF), which support the maturation toward
DA neurons. The CORIN+ cells exhibited reduced prolifer-
ation, and the average diameter of the spheres was smaller
than that of the unsorted cells on both days 28 and 42
(Figures S3A and S3B). Consistently, the sorted CORIN+
cells contained a lower percentage of proliferating
(KI67+) cells compared to the unsorted cells on day 28
(Figures S3C and S3D). There were no Oct3/4+ or Nanog+
cells in these spheres (data not shown). An immunofluo-
rescence study of the cultured day 12 CORIN+ cells dis-
closed that the percentage of FOXA2+ cells was 70%–
75%, which was higher than that of the unsorted cells
on both days 28 and 42 (Figures 3A–3D). The NURR1+
cells were dominant on day 28 (27.3% ± 5.5% and
2.1% ± 1.2% for NURR1+ and TH+ cells, respectively),
whereas the ratio of the TH+ cells increased on day 42
(19.9% ± 6.9% and 42.0% ± 4.4% for NURR1+ and TH+
cells, respectively). Next, we compared the dopamine
secretion between the cultured day 12 CORIN+ cells and
the unsorted cells. A high-performance liquid chromatog-
raphy (HPLC) analysis on day 56 revealed that dopamine
and its metabolite, DOPAC, were more abundantly
released in the cultures of the CORIN+ cells (Figures 3E
and 3F) than of the unsorted cells. The secretion of sero-
tonin was not detected in either of the cultures (data
not shown). These in vitro results suggested that the day
12 CORIN+ cells were less proliferative and more effi-
ciently gave rise to mature midbrain DA neurons
compared to the unsorted cells.
Grafts Derived from the CORIN+ Cells Are Less
Expansive
In order to investigate the survival, proliferation, and
function of the cultured CORIN+ cells in vivo, we injected
the unsorted and the CORIN+ cells (4 3 105 cells in 2 ml)
into the putamen of 6-OHDA-lesioned rats. To find the
optimal differentiation stage of the donor cells, we sorted
the CORIN+ cells on day 12, continued the sphere culture,
and grafted the cells on day 28 or 42. When the cells
were grafted on day 28, the graft sizes of unsorted cells
showed variation from 88.4 to 0.5 mm3 (n = 11) at
16 weeks after transplantation, whereas those of the
CORIN+ cells were more evenly distributed, ranging in
size from 8.5 to 1.5 mm3 (n = 7, Figure 4A). Furthermore,
there were significant differences between the average
sizes (35.0 ± 37.5 mm3 versus 3.4 ± 2.9 mm3 for the
unsorted and the CORIN+ cells, respectively). The percent-
age of proliferating (KI67+) cells was less than 1% in both
cases but was significantly lower in the grafts derived
from the CORIN+ cells (0.06% ± 0.07%) than in those
derived from the unsorted cells (0.86% ± 0.53%; FiguresStem C4C–4E). When the cells were grafted on day 42, the average
graft sizes were less than 1 mm3 in both cases (n = 6 or 7,
Figure 4B), and we could not find any KI67+ cells in these
grafts.
Cultured Day 12 CORIN+ Cells Resulted in Better
Survival of DA Neurons and Greater Behavioral
Improvement
Next, in order to evaluate the function of the grafted
cells, we analyzed the amphetamine-induced rotation of
6-OHDA-lesioned rats, which is caused by an imbalance
of dopamine concentration between the right and
left putamen (Ungerstedt and Arbuthnott, 1970). When
the day 12 CORIN+ or the unsorted cells were grafted
on day 28, the abnormal rotations were reduced by
both of the cell types at 16 weeks (Figures 5A and
S4A). An immunofluorescence study at 16 weeks showed
that more TH+ cells survived and exhibited neurite
outgrowth in the grafts derived from the day 12 CORIN+
cells compared to those from the unsorted cells (6,747 ±
2,341 versus 3,436 ± 2,384 cells/graft; Figures 5C–5G
and S4B). The percentages of TH+ cells per total neurons
(NEUN+) or total surviving cells (HNA+) were also
higher in the grafts derived from the day 12 CORIN+ cells
than those from the unsorted cells (Figures 5I and 5J),
consistent with the in vitro data indicating that DA
progenitor cells were enriched in the sorted CORIN+
cells. These TH+ cells coexpressed markers for midbrain
DA neurons, including FOXA2, NURR1, and PITX3 (Fig-
ure 5K). About half of the TH+ cells also expressed
GIRK2 (a marker for A9 DA neurons that project from
the substantia nigra to the striatum). Serotonergic neu-
rons, which may cause graft-induced dyskinesia, are
generated in the ventral basal plate of the rostral hind-
brain outside the floor plate. Therefore, the sorting of
the CORIN+ cells can exclude serotonergic neurons. The
percentages of serotonin+ cells per total neurons were
very low: 2.5% ± 2.5% and 1.2% ± 0.8% for the unsorted
and the day 12 CORIN+ cells, respectively (Figures 5L
and 5M).
In contrast, when the cells were grafted on day 42, sig-
nificant behavioral improvement was not observed with
either the unsorted or day 12 CORIN+ cells (Figures 5B
and S4C). There were no differences in the number of the
TH+ cells between the grafts derived from the unsorted or
theCORIN+ cells at 16weeks (Figures 5H). It isworthnoting
that when the day 12 CORIN+ cells were grafted on day 42,
the average numbers of surviving TH+ cells were lower
compared to those grafted on day 28: 6,747 ± 2,341 versus
1,900 ± 658 cells/graft for day 28 and 42, respectively (Fig-
ures 5G and 5H).
When the CORIN+ cells were sorted on day 21 and
grafted on day 28 or 42, we could not observe a reductionell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Authors 341
Figure 3. DA Differentiation of the Unsorted and the Day 12 CORIN+ Cells
(A and B) Double-labeled immunostaining of the spheres on day 28 and day 42. FOXA2/DAPI (left) and NURR1/TH (right). Insets indicate
magnified images of double-positive cells. Scale bars, 100 mm.
(C and D) The percentages of NURR1+, FOXA2+, and TH+ cells per total cells on day 28 (C) or day 42 (D). The values are the mean ± SD. (C)
**p = 0.0011 for NURR1, ***p = 0.0002 for FOXA2, and **p = 0.0058 for TH, and (D) ****p < 0.0001 for FOXA2 and TH by the unpaired t test
(n = 6 independent experiments).
(E and F) The results of the HPLC analysis of the dopamine and DOPAC releases by the day 56 cultured cells under high potassium
stimulation. The values are the mean ± SD. **p = 0.0043 for DA and **p = 0.0045 for DOPAC by an unpaired t test (n = 3 independent
experiments).
See also Figure S3 and Table S6.
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lesioned rats in either case (n = 4 or 5, Figures S4D–S4G).
The numbers of the TH+ cells in these grafts were lower
compared to the grafts derived from the day 12 CORIN+
cells (Figure S4H).342 Stem Cell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The AuthCultured Day 12 CORIN+ Cells on Day 28 Are in the
Premature Stage of Development into Midbrain DA
Neurons
As shown above, the best survival of the TH+ cells was
obtained when the CORIN+ cells were sorted on day 12ors
Figure 4. The Proliferation of the Un-
sorted or the Day 12 CORIN+ Cells In Vivo
(A and B) The graft volumes at 16 weeks.
The day 12 CORIN+ cells were grafted on day
28 (n = 11 for unsorted, n = 7 for CORIN+)
(A) or day 42 (n = 6 for unsorted, n = 7 for
CORIN+) (B). Values are the mean ± SD. *p =
0.0435 by the unpaired t test.
(C) Immunohistochemistry for the human
nuclear antigen (HNA). Scale bars, 1 mm.
(D) Immunofluorescence images of the
squares in (C) for HNA (green) and KI67
(red). Scale bars, 50 mm. Insets show
magnified images of KI67+ cells.
(E) The percentages of proliferating (KI67+)
cells per donor cells (HNA+). ****p <
0.0001 by the unpaired t test. The values
are the mean ± SD (n = 5 animals).
See also Table S6.
Stem Cell Reports
Isolation of hiPSC-Derived DA Progenitors to Graftand grafted on day 28. In order to assess the identity of the
donor cells, we performed the microarray analyses to
compare the gene expression profiles between the day 12
CORIN+ cells on day 28 and the unsorted cells on day 28
as well as the day 12 CORIN+ cells on day 28 and the day
12 CORIN+ cells on day 42. The comparison between the
day 12 CORIN+ cells and unsorted cells on day 28 revealed
a higher level of expression of a forebrain marker, PAX6, in
the unsorted cells (Figures 6A and 6B; Table S2). In contrast,
higher expression of ALCAM, as well as CORIN, was
observed in the CORIN+ cells. The comparison between
the day 28 cells and the day 42 cells revealed higher expres-
sion of SHH, WNT5A, and CORIN in the day 28 cells and
higher expression of TH in the day 42 cells (Figures 6C
and 6D; Table S3).
In previous clinical trials, transplantation of fetal ventro-
mesencephalic (VM) cells improved the neurological defi-
cits of patients with PD (Lindvall et al., 1990; Piccini
et al., 1999; Brundin et al., 2000; Mendez et al., 2005; Kefa-
lopoulou et al., 2014). Therefore, we compared the gene
expression between the cultured day 12 CORIN+ cells andStem Cthe VM tissue of a human 7.5-week-old fetus. A quantita-
tive PCR analysis revealed that there was higher expression
of mature DA neuron markers, such as TH and PITX3, in
the fetal tissue compared to the day 12 CORIN+ cells on
day 28 (Figure 6E). It should be noted that the expression
level of TPH2, a marker of serotonergic neurons, was
much lower in the CORIN+ cells. A microarray analysis re-
vealed that the cultured day 12 CORIN+ cells on day 28
were in the earlier developmental stage than the human
fetal VM tissue, which expressed genes related to axon
guidance, such as SPON1 and SLIT2 (Figure S5; Table S4).
Hierarchical clustering of the global gene expression dis-
closed that fetal VM tissue is more closely related to the
day 12 CORIN+ cells on day 42 than those on day 28
(Figure 6F).DISCUSSION
In this study, we demonstrated that DA progenitor cells are
enriched in the sorted CORIN+ cells derived from humanell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Authors 343
(legend on next page)
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in the CORIN+ cell-derived grafts compared to those from
the unsorted cells and improved the behavior of the
6-OHDA-lesioned rats. The CORIN+ cell-derived grafts
contained only a few (<0.1%) proliferating cells, suggesting
that they are associated with minimal risk of tumor forma-
tion. In addition, we have developed a highly efficient
method for DA neuron induction on xeno-free, chemically
defined human laminin fragment.
We inducedmidbrain DA neurons by attachment culture
on LM511-E8. Laminin is a heterotrimeric glycoprotein
composed of three covalently linked chains that are termed
a, b, and g (Miner et al., 2004); specifically a5, b1, and g1
for LM511. The full-length (Rodin et al., 2010; Miyazaki
et al., 2008) and short fragment (Miyazaki et al., 2012) of
laminin-511 supports the stable culture of PSCs. The adhe-
sion of human PSCs to LM511-E8 is primarily a6b1-integ-
rin dependent (Miyazaki et al., 2012), and the laminin
interactions with the a6b1-integrin play an important
role as an early inductive signal to regulate the prolifera-
tion, migration, and fate decision of ESC-derived neural
cells (Ma et al., 2008) and the differentiating neural cells
in the embryonic brain (Lathia et al., 2007). Consistently,
LM511-E8 efficiently supported the neural induction
from human iPSCs and the survival of the differentiated
cells. Furthermore, we were able to obtain more than 24
times the number of differentiated neural cells per dish
compared to our previous feeder-free floating method
(Morizane et al., 2011). The use of xeno-free matrix (Swis-
towski et al., 2009) and the floating culture of cell aggrega-
tions (Eiraku et al., 2008; Morizane et al., 2011; Kirkeby
et al., 2012) have both been introduced to avoid animal-
derived feeder cells in order to facilitate the future clinical
application of the PSCs. Our high-density attachment cul-
ture on LM511-E8 yielded a higher number of neural cellsFigure 5. The Survival and Function of DA Neurons Derived from
Grafted on Day 28 or Day 42
(A and B) The methamphetamine-induced rotation of the rats with th
**p = 0.0017 (unsorted, 16 weeks), and ***p = 0.0003 (CORIN+, 16 we
n = 6, medium injection and nonlesioned; n = 11, day 28 unsorted
respectively.
(C–F) DAB staining of the representative grafts derived from day 28 COR
images of consecutive sections throughout the striatum are shown. (D
right panels are the magnified images of the flames in the left panel
(G and H) The number of TH+ cells in each graft. The values are the m
(I and J) The rates of TH+ cells per neuronal cells (NEUN+) (I) and TH
unpaired t test. The values are the mean ± SD.
(K) Immunostaining of the grafts derived from day 12 CORIN+ cells for
(L) Immunofluorescent images for SEROTONIN(green)/TH(red)/NEUN
(M) The percentages of the SEROTONIN+ cells per surviving neurons
differences.
See also Figure S4 and Table S6.
Stem Cmore easily and seems to be suitable for clinical
application.
With regard to safety issues, prolonged differentiation
(Brederlau et al., 2006; Doi et al., 2012) and purification
of neurally committed cells (Fukuda et al., 2006; Pruszak
et al., 2009; Sundberg et al., 2013) have been attempted
to reduce the risk of tumor formation. Recently, a dual
SMAD inhibition and floor plate induction protocol was
shown to reduce the induction of PAX6+ progenitor cells
with a rostral identity, which may have a potential of
continuous proliferation in the brain (Fasano et al., 2010;
Kriks et al., 2011; Figure S1C). The risk of proliferation of
the early neural or nonneural cells, however, cannot be
ignored. Consistently, the graft sizes derived from the un-
sorted cells on day 28 widely ranged from 88.4 to
0.5 mm3 at 16 weeks. In contrast, the graft sizes from
the day 12 CORIN+ cells were relatively constant
(8.5–1.5 mm3), and the average size was significantly
smaller. In addition, the percentage of proliferating cells
was much lower in the CORIN+ cell-derived grafts, indi-
cating that the purification of CORIN+ cells contributes to
the safety of the cell replacement therapy.
The purity of midbrain DA neurons among the donor
cells is one of the keys to the functional recovery after
transplantation. The sorting of CORIN+ cells on day 12
could enrich the LMX1A+/FOXA2+ DA progenitor cells
from 47% to 76% of the total cells. This increase in the
number of DA neurons was also confirmed in vivo when
the day 12 CORIN+ cells were grafted on day 28. Behavioral
improvement was observed by the transplantation of both
the unsorted and the cultured CORIN+ cells, probably
because the 300 surviving TH+ cells in the unsorted cell
grafts were sufficient to exert such an effect (Brundin
et al., 1988). However, the ratio of TH+ cells to the total sur-
viving cells was much higher in the CORIN+ cell-derivedthe Unsorted or the Day 12 CORIN+ Cells In Vivo, which Were
e grafts. The values are the mean ± SEM. *p = 0.0482 (12 weeks),
eks) by a two-way ANOVA with Dunnett’s multiple comparisons test:
; n = 6, day 42-unsorted; and n = 7, day 28- and day 42 CORIN+,
IN+ or day 28-unsorted cells stained for TH. (C and E) The low-power
and F) The magnified images of flames in (C) and (E) are shown. The
s. Scale bars, 200 mm.
ean ± SD. *p = 0.0106 by the unpaired t test.
+ cells per surviving donor cells (HNA+) (J). ****p < 0.0001 by the
FOXA2/TH, PITX3/TH, NURR1/TH, and GIRK2/TH. Scale bars, 50 mm.
(blue). Arrowheads indicate SEROTONIN+ cells. Scale bars, 100 mm.
(NEUN+). The values are the mean ± SD. There were no significant
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Figure 6. The Results of the Gene Expression Analysis of the iPSC-Derived Cells and Human Fetal Cells
(A–D) The results of the microarray analysis comparing the unsorted versus CORIN+ cells on day 28 (A and B) and the CORIN+ cells on day 28
versus on day 42 (C and D). (A and C) Scatterplots. (B and D) Selected genes of differentially expressed transcripts comparing (B) day 28
CORIN+ versus day 28 unsorted cells and (D) day 28 CORIN+ versus day 42 CORIN+ cells are shown.
(E) The results of the quantitative RT-PCR analysis in the CORIN+ cells and human fetal VM tissue. The expression of the VM tissue was set
to 1. The values are the mean ± SD (n = 3 independent experiments).
(F) The hierarchical clustering of the global gene expression data obtained from the iPSC-derived cells and human fetal VM tissue.
See also Figure S5 and Tables S2 and S3–S5.
Stem Cell Reports
Isolation of hiPSC-Derived DA Progenitors to Graftgrafts: at 0.3% versus 18% for the unsorted and the CORIN+
cells, respectively. Recently, two studies of transplantation
of human ESC-derived DA progenitor cells into rat brains
have been reported, in which a dual SMAD inhibition
and floor plate induction protocol was applied (Kriks
et al., 2011; Kirkeby et al., 2012). Both studies showed
that about 80% of the total cells on day 11 were
LMX1A+/FOXA2+, but the ratios of TH+ cells in the grafts
at 16 weeks (Kriks et al., 2011) and 18 weeks (Kirkeby346 Stem Cell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Authet al., 2012) were 6% and 54%, respectively. This decreased
ratio of DA neurons in the graft may be due to the vulner-
ability of DA neurons, or it may take a longer time period
for grafted progenitor cells to become fully mature DA
neurons. Optimization of the host brain environment
might improve the survival or maturation of the grafted
DA progenitor cells.
It is noteworthy that the number of TH+ cells per graft
decreased when the day 12 CORIN+ cells were engraftedors
Stem Cell Reports
Isolation of hiPSC-Derived DA Progenitors to Grafton day 42 compared to day 28. A recent analysis using
transgenic mouse ESC reporter lines concluded that the
Nurr1+ stage (middle stage) of neuronal differentiation is
particularly suitable and led to the best survival of the
ESC-derived DA neurons (Ganat et al., 2012). In our study
with human iPSCs, the NURR1+ cells were dominant
compared to the TH+ cells on day 28. Intriguingly, a com-
parison of the gene expression profiles revealed that the
cultured day 12 CORIN+ cells on day 42 were more closely
related to the human 7.5-week fetal VM tissue, and mature
DA neuron markers, such as TH and PITX3, were more
abundantly expressed in both of these. Taken together,
our results suggest that the cultured day 12 CORIN+ cells
on day 28 are in the premature stage of the midbrain DA
neurons and may be suitable donor cells for the treatment
of PD.
In conclusion, we have developed a method for (1) scal-
able DA neuron induction on human laminin fragments,
and (2) sorting DA progenitor cells using an anti-CORIN
antibody. Furthermore, we determined the optimal timing
for the cell sorting and transplantation. ThegraftedCORIN+
cells survived well and functioned as midbrain DA neurons
in the6-OHDA-lesioned rats and showedminimal risk of tu-
mor formation. For the clinical application of iPSCs, the
scalability and reproducibility of the donor cell preparation
are critical. These results suggest that our strategy is advan-
tageous in terms of scalability, safety, and efficiency and can
be applied to the cell replacement therapy for PD.EXPERIMENTAL PROCEDURES
Coating of Extracellular Matrices
The 24-well or 6-well cell culture plates (BD Falcon) were precoated
with extracellular matrices (ECMs) at a concentration of 1:20 for
MG, 1:50 for CS (Ausubel et al., 2011; Bergstro¨m et al., 2011),
1 mg/cm2 for LM111, and 0.5 mg/cm2 for LM511-E8 and were incu-
bated for 2 hr at 37C just before cell seeding. To dilute the ECMs,
Dulbecco’s PBS(+) was used for CS, PBS() for LM111 and LM511-
E8, and the culture media were used for MG.Human iPSC Culture
This study was approved by the ethical committees of Kyoto Uni-
versity, Kyoto. Human iPSCs (404C2 and 836B3) were initially
maintained on SNL feeder layers in Dulbecco’s modified Eagle’s
medium (DMEM)/F-12 (Sigma-Aldrich) supplemented with
0.1 mM 2-mercaptoethanol (Wako Pure Chemicals Industries),
20% knockout serum replacement (KSR; Invitrogen), 0.1 mM
nonessential amino acids (Invitrogen), 2 mM L-glutamine, and
5 ng/ml bFGF (Invitrogen). When passaging the cells to LM511-
E8-coated dishes, the iPSCs were dissociated into single cells with
TrypLE select (Invitrogen) and replated at a density of 1.5 3 104
cells per 6-well plate with StemFit media (Ajinomoto). After they
were passaged three times to remove the feeder cells, the iPSCs
were used for experiments.Stem CNeural Induction from Human iPSCs
Human iPSCs were dissociated into single cells after 10 min of in-
cubation with TrypLE select and were plated on LM511-E8-coated
6-well plates at a density of 43 105 cells. After 4 days of culture, the
iPSCs reached a confluent state, and the maintenance media (the
StemFitmedia) were changed to the differentiationmedia contain-
ing GMEM supplemented with 8% KSR, 0.1 mM MEM nonessen-
tial amino acids (all Invitrogen), sodium pyruvate (Sigma-Aldrich),
and 0.1 mM 2-mercaptoethanol. We added LDN193189
(STEMGENT) and A83-01 (Wako) to efficiently induce neuronal
differentiation (Morizane et al., 2011). We also added purmorph-
amine and FGF8 (Wako) from day 1 to day 7, and CHIR99021
(Wako/STEMGENT) fromday 3 to day 12, to induce floor plate cells
(Kriks et al., 2011).
After cell sorting on culture day 12, the sorted cells were replated
on low cell adhesion 96-well plates (Lipidure-Coat Plate A-96U;
NOF CORPORATION) at a density of 2 3 104 cells/well, in the
neural differentiation media containing Neurobasal medium
supplemented with B27 supplement, 2 mM L-glutamine (all
Invitrogen), 10 ng/ml GDNF, 200 mM ascorbic acid, 20 ng/ml
BDNF (all Wako), and 400 mM dbcAMP (Sigma-Aldrich). We added
30 mMof Y-27632 (Wako) in the first medium to avoid apoptosis at
the initial plating. After that, we changed the media every 3 days.
For in vitro studies in Figure 1, the differentiating cells on LM511-
E8 were detached and dissociated on day 12, replated on low cell
adhesion 96-well plates in the neural differentiation media. The
floating spheres were replated on O/F/L-coated plates or 8-well
chamber slides on day 28, then cultured with the neural differenti-
ation media until day 42.
Quantitative RT-PCR
Total RNA was isolated using an RNeasy Mini or Micro Kit
(QIAGEN), and cDNA was synthesized from 1 mg of RNA using
a SuperScript III First-Strand Synthesis System (Invitrogen). Quan-
titative PCRs were carried out with SYBR Premix Ex Taq (TaKaRa)
and the Thermal Cycler Dice Real Time System (TaKaRa). The
data were assessed using a delta-Ct method and normalized by
the GAPDH expression. The primer sequences used are shown in
Table S5.
Immunofluorescence Studies
Double- or triple-labeled immunohistochemical analyses were
carried out after permeabilization and blocking with 0.3% Triton
X-100 and 2% skim milk. The immunoreactive cells were visual-
ized using a fluorescent microscope (BZ-9000; Keyence) and a
confocal laser microscope (Fluoview FV1000D; Olympus). The pri-
mary antibodies used are described in Table S6.
Dopamine Release Assay
Human iPSC-derived neural cells (culture day 28) were differenti-
ated on O/F/L-coated 24-well plates for 28 days, then were washed
twice with a low KCl (4.7 mM) solution and incubated in the low
KCl solution for 15 min. The medium was subsequently replaced
with a high KCl solution (60 mM) for 15 min. The solution was
then collected, and the concentration of dopamine was deter-
mined byHPLCusing a reverse-phase columnand an electrochem-
ical detector system (HTEC-500; Eicom).ell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Authors 347
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Whole-cell patch-clamp recordings were performed on 42- to
84-day cultured neurons grown on O/F/L-coated glass coverslips.
Neuronswith a large cell body andneurite-like structures were cho-
sen for examination. The cells were maintained in a physiological
saline solution with the following composition: 125 mM NaCl,
2.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 26 mM NaHCO3,
1.25 mM NaH2PO4, and 17 mM glucose. Patch pipettes were
made from borosilicate glass capillaries (GC150TF-10; Clark) and
had a resistance of 3–4 MW when filled with an internal solution
composed of 140 mM KCl, 10 mM HEPES, and 0.2 mM EGTA
(pH 7.3). Recordings with a voltage clamp and current clamp
were done with a patch-clamp amplifier (EPC-8; HEKA). The giga-
seal resistances were in the range of 10–20 GW. The current signals
from the amplifier were filtered at 5 kHz through a four-pole low-
pass filter with Bessel characteristics (UF-BL2; NF), sampled with
a 12-bit A/D converter, and were stored on a 32-bit computer
(PC-9821Ra333; NEC). All experiments were performed at room
temperature.
Cell Sorting
For the analysis, cells were harvested using Accumax, were gently
dissociated into a single cell suspension, and resuspended in
phenol-free, Ca2+Mg2+-free Hank’s balanced salt solution (HBSS;
Invitrogen) containing 2% FBS, 10 mM Y-27632 (Wako), 20 mM
D-glucose (Wako), and 50 mg/ml penicillin/streptomycin
(Invitrogen). Samples were filtered through cell-strainer caps
(35 mm mesh; BD Biosciences) and then subjected to surface
marker staining using a PE-conjugated anti-TRA-1-60 antibody
(BD PharMingen), anti-PSA-NCAM antibody (1:100; Millipore),
and Alexa 488-conjugated anti-mouse IgM antibody (1:400;
Invitrogen), or an anti-CORIN antibody (1:200; a gift from the
KAN laboratory) and Alexa 488-conjugated anti-mouse IgG or
IgM antibodies (1:400; Invitrogen). The antibodies were added
and incubated at 4C for 20min, and then cells were washed twice
with HBSS buffer. Dead cells and debris were excluded by 7-AAD
staining. The analysis was performed using a FACSAria II cell sorter
or a BD LSRFortessa flow cytometer and the FACSDiva software
program (BD Biosciences). A 100 mm ceramic nozzle (BD Biosci-
ences), with a sheath pressure of 20–25 psi and an acquisition
rate of 3,000–5,000 events/s, was used for sorting. Positive staining
was set so that less than 0.1% of events exceeded the threshold in
samples lacking primary antibodies. The sorted cells were collected
and replated in U-shaped 96-well plates (Lipidure-Coat Plate
A-96U; 2 3 104 cells/well) with culture medium containing
30 mM Y-27632.
Animals and Cell Transplantation
Animals were cared for and handled according to the Guidelines
for Animal Experiments of Kyoto University and the Guide for
the Care and Use of Laboratory Animals of the Institute of Labora-
tory Animal Resources (ILAR; Washington, DCA). Adult female
Sprague-Dawley rats (SHIMIZU LABORATORY SUPPLIES) weigh-
ing 200–250 g were used for the 6-OHDA-lesioned model. The
rats were injected with 6-OHDA into the medial forebrain bundle
in the right hemisphere. The coordinates were calculated with
reference to the bregma: anterior (A),4.4; lateral (L),1.2; ventral348 Stem Cell Reports j Vol. 2 j 337–350 j March 11, 2014 j ª2014 The Auth(V),7.8; and tooth bar (TB),2.4. A total of 16 mg of 6-OHDAwas
injected per rat in 2.5 ml of saline with 0.02% ascorbic acid. Cell
transplantation was performed with stereotactic injection of 4 3
105 cells in 2 ml (200,000 cells/ml, 1 ml/10 s) through a 22G needle
into the right side of the striatum (from the bregma: A, +1.0; L,
3.0; V, 5.0 and 4.0; and TB, 0). Sixteen weeks after transplan-
tation, the animals were euthanized with pentobarbital and
perfused transcardially with 4% paraformaldehyde. The brains
were cut with a cryostat at 35 mm thickness and mounted. A total
of 12 sections containing the graft region from each rat were
chosen for the immunofluorescence study. The graft sizewas calcu-
lated from the area stained for the anti-HNA antibody, using the
Bioanalyzer software program (Keyence).Behavioral Analysis
The methamphetamine-induced rotation assay was performed
pretransplantation and every 4 weeks after transplantation using
video-monitored rotational bowls. A dose of 2.5mg/kg ofmetham-
phetamine (Dainippon Sumitomo Pharma) was injected intraper-
itoneally, and the rotations were recorded for 90min. Only the rats
that showed more than six rotations per minute were used as graft
recipients. Nonlesioned rats showed no induced net turns (Fig-
ure 5A, pre).Microarray Analyses
For the microarray analyses, the total RNA was processed using an
Ambion WT Expression Kit and Affymetrix GeneChip Whole-
Transcript (WT) Expression Arrays (Ambion, Life Technologies).
Comparisons were performed among the unsorted, sorted, and
the human fetal VM sample (gestational age of 7.5 weeks) using
the GeneSpring software program (version 12.5; Agilent Technolo-
gies). Genes found to have an adjusted value of p < 0.05 and a fold
change greater than two were considered to be significant.Statistical Analysis
The statistical analyses were performed using a commercially avail-
able software package (GraphPad Prism 6; GraphPad Software).
Data from the in vitro and in vivo experiments were analyzed by
a one-factor ANOVA and Tukey’s post hoc analysis (Figures 1C
and S1A) or Dunnett’s multiple comparisons test (Figures 2E, 2F,
and S2D) or an unpaired t test (Figures 3C, 3D, 3F, 4A, 4B, 4E,
5G–5J, 5M, and S3B). The behavioral data were analyzed by a
two-way ANOVA with Dunnett’s multiple comparisons test (Fig-
ures 5A and 5B). The differences were considered to be statistically
significant for values of p < 0.05. The data are presented as the
mean ± SD, except for the behavioral data (mean ± SEM).
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